Acasti Pharma Inc Forward P/E
What is the Forward P/E of Acasti Pharma Inc?
The Forward P/E of Acasti Pharma Inc is -3.61
What is the definition of Forward P/E?
Forward price to earnings ratio is the ratio of a company’s stock price to the company’s estimated earnings per share for the next twelve months.
The forward price to earnings ratio is similar to trailing price to earnings ratio but instead of net income uses estimated net earnings over next 12 months. Estimates are typically derived as the mean of those published by a select group of analysts with selection criteria varying. The forward price-to-earnings ratio is a powerful, but limited tool. It allows a quick snapshot of the company’s finances without getting down in the details of an accounting report.
Forward P/E of companies in the Health Care sector on NASDAQ compared to Acasti Pharma Inc
What does Acasti Pharma Inc do?
acasti pharma, inc., a subsiduary of neptune technologies & bioressources, is a quebec-based biopharmaceutical dedicated in advancing a proprietary portfolio based on marine phospholipids. our products can be used in prescription, medical food and over-the-counter applications, either as a stand-alone, or, as a fixed-dose combination to exisitng productrs, for the prevention and treatment of cardiometabolic disorders.
Companies with forward p/e similar to Acasti Pharma Inc
- Vir Biotechnology Inc has Forward P/E of -3.70
- Rare Element Resources has Forward P/E of -3.68
- comScore has Forward P/E of -3.68
- Cellectis SA has Forward P/E of -3.65
- InflaRx N.V has Forward P/E of -3.63
- Medicinova Inc has Forward P/E of -3.61
- Acasti Pharma Inc has Forward P/E of -3.61
- comScore has Forward P/E of -3.61
- comScore has Forward P/E of -3.61
- Standard BioTools Inc has Forward P/E of -3.60
- Arbutus Biopharma Corp has Forward P/E of -3.60
- comScore has Forward P/E of -3.59
- comScore has Forward P/E of -3.59